
Avalo Therapeutics Investor Relations Material
Latest events

Q2 2025
7 Aug, 2025

Corporate Presentation
19 Jun, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Avalo Therapeutics Inc
Access all reports
Avalo Therapeutics Inc. is a U.S.-based biotechnology company focused on the development of targeted therapies for immune-mediated diseases. The company specializes in discovering and advancing treatments for autoimmune and rare diseases by leveraging its expertise in immunology and precision medicine. Avalo Therapeutics Inc. conducts research across various stages of drug development, from early discovery to clinical trials. The company is headquartered in Rockville, Maryland, and its shares are listed on the NASDAQ.
Key slides for Avalo Therapeutics Inc


Corporate Presentation
Avalo Therapeutics Inc


Corporate Presentation
Avalo Therapeutics Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
AVTX
Country
🇺🇸 United States